NAD replenishment with nicotinamide mononucleotide protects blood–brain barrier integrity and attenuates delayed tissue plasminogen activator‐induced haemorrhagic transformation after cerebral ischaemia
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Background and Purpose: Tissue plasminogen activator (tPA) is the only approved pharmacological therapy for acute brain ischaemia; however, a major limitation of tPA is the haemorrhagic transformation that follows tPA treatment. Here, we determined whether nicotinamide mononucleotide (NMN), a key intermediate of nicotinamide adenine dinucleotide biosynthesis, affects tPA‐induced haemorrhagic transformation. Experimental Approach: Middle cerebral artery occlusion (MCAO) was achieved in CD1 mice by introducing a filament to the left MCA for 5 h. When the filament was removed for reperfusion, tPA was infused via the tail vein. A single dose of NMN was injected i.p. (300 mg·kg−1). Mice were killed at 24 h post ischaemia, and their brains were evaluated for brain infarction, oedema, haemoglobin content, apoptosis, neuroinflammation, blood–brain barrier (BBB) permeability, the expression of tight junction proteins (TJPs) and the activity/expression of MMPs. Key Results: In the mice infused with tPA at 5 h post ischaemia, there were significant increases in mortality, brain infarction, brain oedema, brain haemoglobin level, neural apoptosis, Iba‐1 staining (microglia activation) and myeloperoxidase staining (neutrophil infiltration). All these tPA‐induced alterations were significantly prevented by NMN administration. Mechanistically, the delayed tPA treatment increased BBB permeability by down‐regulating TJPs, including claudin‐1, occludin and zonula occludens‐1, and enhancing the activities and protein expression of MMP9 and MMP2. Similarly, NMN administration partly blocked these tPA‐induced molecular changes. Conclusions and Implications: Our results demonstrate that NMN ameliorates tPA‐induced haemorrhagic transformation in brain ischaemia by maintaining the integrity of the BBB.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Animal research: Reporting in vivo experiments: The ARRIVE guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00872.x · Cited by 3,625
Animal Research: Reporting in vivo Experiments—The ARRIVE Guidelines
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2010.220 · Cited by 2,012
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481 · cited 3×
“Although all of them are major users of NAD, increasing NAD levels result in the activation of sirtuins but inhibition of PARP1/CD38 (Imai and Guarente, 2014; Garten et al., 2015; Wang and Miao, 2015).”
BackgroundYoshino, J., Mills, K. F., Yoon, M. J., & Imai, S.-I. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.08.014 · Cited by 1,340
McGrath, J. C., & Lilley, E. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12955 · Cited by 1,321
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060 · cited 2×
“This results in the disruption in the integrity of the BBB (Yang et al., 2007).”
BackgroundAge-Associated Changes In Oxidative Stress and NAD+ Metabolism In Human Tissue
Massudi, H., Grant, R., Braidy, N., Guest, J., Farnsworth, B., & Guillemin, G. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042357 · Cited by 545 · cited 1×
“Depletion of intracellular NAD is a common pathway in many pathophysiological events, including ageing, metabolic disorders and cerebral ischaemia (Yang et al., 2002; Massudi et al., 2012; Zhang et al., 2016; Zhou et al., 2016; Wang et al., 2016a).”
BackgroundPicciotto, N. E., Gano, L. B., Johnson, L. C., Martens, C. R., Sindler, A. L., Mills, K. F., Imai, S., & Seals, D. R. (2016) · Aging Cell · doi:10.1111/acel.12461 · Cited by 396
Stein, L. R., & Imai, S. (2014) · The EMBO Journal · doi:10.1002/embj.201386917 · Cited by 265 · cited 1×
“However, most studies applied the dose of 300 mg·kg 1 (Wang et al., 2011; Yoshino et al., 2011; Zhang et al., 2011; Stein and Imai, 2014; Zhao et al., 2015b; de Picciotto et al., 2016; Wei et al., 2017); therefore, we used 300 mg·kg 1 in this study.”
MethodUddin, G. M., Youngson, N. A., Sinclair, D. A., & Morris, M. J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00258 · Cited by 95 · cited 2×
“In previous studies, NMN was administered to mice at doses of ~100 mg·kg 1 (Park et al., 2016) to 500 mg·kg 1 (Long et al., 2015; Uddin et al., 2016).”
BackgroundMethod
Cited by
NAD+ metabolism and its roles in cellular processes during ageing
Covarrubias, A. J., Perrone, R., Grozio, A., & Verdin, E. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00313-x · Cited by 1,617
NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR
Yoshino, J., Baur, J. A., & Imai, S.-I. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.002 · Cited by 1,061
“…(IV and IP) single 7 days reduced brain edema and cell death (one bolus) and promoted the recovery of body weight and neurological function (7 days) Wei et al., 2017a Old C57BL/6J mice and young irradiated C57BL/6J mice unspecified 500 mg/kg (IP) 2000 mg/kg (PO) 7 days 8 days reduced DNA damage…”
Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence
Rajman, L., Chwalek, K., & Sinclair, D. A. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.011 · Cited by 865
Cai, Y., Yang, E., Yao, X., Zhang, X., Wang, Q., Wang, Y., Liu, J., Fan, W., Yi, K., Kang, C., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2020.101792 · Cited by 196
Kiss, T., Nyúl-Tóth, Á., Balasubramanian, P., Tarantini, S., Ahire, C., Yabluchanskiy, A., Csipo, T., Farkas, E., Wren, J. D., Garman, L., et al. (2020) · GeroScience · doi:10.1007/s11357-020-00165-5 · Cited by 163
Metadata
- Authors
- Wei, C., Kong, Y., Hua, X., Li, G., Zheng, S., Cheng, M., Wang, P., & Miao, C.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2017-09-06
- Volume
- 174
- Issue
- 21
- Pages
- 3823-3836
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2784532114
- Cited by
- 85
- References
- 11
- FWCI
- 4.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.